ES2127294T3 - Vacunas del virus de la inmunodeficiencia anti-felino (fiv). - Google Patents

Vacunas del virus de la inmunodeficiencia anti-felino (fiv).

Info

Publication number
ES2127294T3
ES2127294T3 ES93920971T ES93920971T ES2127294T3 ES 2127294 T3 ES2127294 T3 ES 2127294T3 ES 93920971 T ES93920971 T ES 93920971T ES 93920971 T ES93920971 T ES 93920971T ES 2127294 T3 ES2127294 T3 ES 2127294T3
Authority
ES
Spain
Prior art keywords
ivf
vaccines
feline immunodeficiency
immunodeficiency viruses
combat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93920971T
Other languages
English (en)
Inventor
Michael James Francis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of ES2127294T3 publication Critical patent/ES2127294T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL PRESENTE INVENTO PROPORCIONA UN POLIPEPTIDO SINTETICO QUE COMPRENDE TODA O PARTE DE UNA SECUENCIA AMINOACIDA SELECCIONADA DE (I), O UN FRAGMENTO ANTIGENICO, UNA VARIANTE FUNCIONALMENTE EQUIVALENTE O SU SAL FARMACEUTICAMENTE ACEPTABLE. TAMBIEN SE FACILITAN MOLECULAS DE ACIDO NUCLEICO QUE CODIFICAN TALES POLIPEPTIDOS, METODOS DE PREPARACION, COMPOSICIONES DE VACUNAS QUE LAS CONTIENEN Y SU EMPLEO, TANTO PARA COMBATIR EL FIV COMO PARA DIAGNOSTICAR SU INFECCION.
ES93920971T 1992-09-21 1993-09-20 Vacunas del virus de la inmunodeficiencia anti-felino (fiv). Expired - Lifetime ES2127294T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929219936A GB9219936D0 (en) 1992-09-21 1992-09-21 Vaccines

Publications (1)

Publication Number Publication Date
ES2127294T3 true ES2127294T3 (es) 1999-04-16

Family

ID=10722245

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93920971T Expired - Lifetime ES2127294T3 (es) 1992-09-21 1993-09-20 Vacunas del virus de la inmunodeficiencia anti-felino (fiv).

Country Status (11)

Country Link
EP (1) EP0661999B1 (es)
JP (1) JP3604384B2 (es)
AT (1) ATE175119T1 (es)
AU (1) AU4826493A (es)
DE (1) DE69322872T2 (es)
DK (1) DK0661999T3 (es)
ES (1) ES2127294T3 (es)
GB (1) GB9219936D0 (es)
GR (1) GR3029264T3 (es)
WO (1) WO1994006471A1 (es)
ZA (1) ZA936970B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE334216T1 (de) * 1994-04-29 2006-08-15 Pharmacia & Upjohn Co Llc Impstoff gegen felines immunodefizienz-virus
IT1276509B1 (it) * 1995-03-31 1997-10-31 Istituto Superiore Della Sanit Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
DK0848615T3 (da) * 1995-08-25 2005-10-03 Univ Florida Muilti-undertyoe-FIV-vacciner
FR2769916B1 (fr) * 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
GB9827077D0 (en) 1998-12-09 1999-02-03 Expro North Sea Ltd Improvements in or relating to well fluid sampling
DE50010240D1 (de) * 1999-07-08 2005-06-09 Mologen Forschungs Entwicklung Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze
FR2828687B1 (fr) * 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
FR2828686B1 (fr) * 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
US7201903B2 (en) 2003-09-11 2007-04-10 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2006011919A1 (en) 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7285272B2 (en) 2003-12-18 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
DE602005027326D1 (de) * 2004-02-19 2011-05-19 Idexx Lab Inc Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
US7335360B2 (en) 2004-06-30 2008-02-26 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
US5591572A (en) * 1991-06-14 1997-01-07 St. Vincents Institute Of Medical Research Limited Detection of mammalian immunodeficiency viruses
WO1993001304A1 (en) * 1991-07-10 1993-01-21 Synbiotics Corporation Synthetic peptides related to fiv-env proteins

Also Published As

Publication number Publication date
GB9219936D0 (en) 1992-11-04
JPH08504090A (ja) 1996-05-07
JP3604384B2 (ja) 2004-12-22
ATE175119T1 (de) 1999-01-15
EP0661999A1 (en) 1995-07-12
EP0661999B1 (en) 1998-12-30
AU4826493A (en) 1994-04-12
DE69322872D1 (de) 1999-02-11
GR3029264T3 (en) 1999-05-28
DE69322872T2 (de) 1999-05-27
DK0661999T3 (da) 1999-08-30
WO1994006471A1 (en) 1994-03-31
ZA936970B (en) 1994-08-29

Similar Documents

Publication Publication Date Title
ES2127294T3 (es) Vacunas del virus de la inmunodeficiencia anti-felino (fiv).
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
ATE258188T1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
DK11789D0 (da) Rekombinante vaccinia-vira
DK153290A (da) Polypeptid, vaccine indeholdende dette og ekspressionssystem indeholdende en dna-sekvens, der kan udtrykke polypeptidet
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
ATE134195T1 (de) Peptidfragmente von hiv
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
ES2061603T3 (es) Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos.
NO942707L (no) Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner
ES2085163T3 (es) Vacunas contra los parasitos metazoos.
PT99791A (pt) Processo para a preparacao de peptidos seleccionados do antigene especifico de grupo (gas) do virus da imunodeficiencia humana (hiv) e de composicoes farmaceu-ticas que os contem
ES2077017T3 (es) Vacuna contra el virus de la bronquitis infecciosa.
DK204588D0 (da) Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
ES2055610T3 (es) Vacuna contra hrsv.
ATE105190T1 (de) Ein b-epitop des huellglykoproteins eines retrovirus und ein t-epitop eines anderen proteins dieses retrovirus enthaltende zusammensetzung.
ES2071038T3 (es) Peptidos asociados al hiv.
PL442478A1 (pl) Kompozycja szczepionki do zastosowania w profilaktyce chorób zakaźnych
CA2143187A1 (en) Anti-feline immunodeficiency virus (fiv) vaccines
MX169441B (es) Peptidos capaces de ser reconocidos por anticuerpos inducidos contra el retro-virus de inmunodeficiencia humana (hiv-virus) sus aplicaciones para diagnostico de infecciones causadas por alguno de estos virus y en su caso, para vacunas contra sida
TH64168B (th) รีคอมบิแนนท์ bcg วัคซีน
ES2065254B1 (es) Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661999

Country of ref document: ES